User profiles for E. Erdmann
 | Erland ErdmannProfessor der Medizin Universität Köln Verified email at uni-koeln.de Cited by 48033 |
Sarcoplasmic reticulum Ca2+-ATPase modulates cardiac contraction and relaxation
The cardiac SR Ca 2+ -ATPase (SERCA2a) regulates intracellular Ca 2+ -handling and thus,
plays a crucial role in initiating cardiac contraction and relaxation. SERCA2a may be …
plays a crucial role in initiating cardiac contraction and relaxation. SERCA2a may be …
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular …
JA Dormandy, B Charbonnel, DJA Eckland, E Erdmann… - The Lancet, 2005 - thelancet.com
Background Patients with type 2 diabetes are at high risk of fatal and non-fatal myocardial
infarction and stroke. There is indirect evidence that agonists of peroxisome proliferator-…
infarction and stroke. There is indirect evidence that agonists of peroxisome proliferator-…
† Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text‡: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of …
…, B Charbonnel, E Erdmann, E Ferrannini… - European heart …, 2007 - academic.oup.com
… E-mail address: lars.ryden@ki.se; eberhard.standl@lrz.uni-muenchen.de … Deckers,
Michel Bertrand, Bernard Charbonnel, Erland Erdmann, Ele Ferrannini, Allan Flyvbjerg …
Michel Bertrand, Bernard Charbonnel, Erland Erdmann, Ele Ferrannini, Allan Flyvbjerg …
[HTML][HTML] The effect of cardiac resynchronization on morbidity and mortality in heart failure
JGF Cleland, JC Daubert, E Erdmann… - … England Journal of …, 2005 - Mass Medical Soc
Background Cardiac resynchronization reduces symptoms and improves left ventricular function
in many patients with heart failure due to left ventricular systolic dysfunction and cardiac …
in many patients with heart failure due to left ventricular systolic dysfunction and cardiac …
[BOOK][B] Klinische Kardiologie
E Erdmann, E Erdmann - 2011 - Springer
Auch Bücher werden älter! Gelegentlich schleppen sich überholte Ansichten und alte
Gewohnheiten von Auflage zu Auflage fort. Als Kuriositäten fallen sie dann eines Tages auf und …
Gewohnheiten von Auflage zu Auflage fort. Als Kuriositäten fallen sie dann eines Tages auf und …
Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure.
DJ Beuckelmann, M Näbauer, E Erdmann - Circulation, 1992 - Am Heart Assoc
BACKGROUND Experiments were performed in human ventricular myocytes to investigate
properties of excitation-contraction coupling in patients with terminal heart failure. Myocytes …
properties of excitation-contraction coupling in patients with terminal heart failure. Myocytes …
[HTML][HTML] Adaptive servo-ventilation for central sleep apnea in systolic heart failure
…, C Angermann, MP d'Ortho, E Erdmann… - … England Journal of …, 2015 - Mass Medical Soc
Background Central sleep apnea is associated with poor prognosis and death in patients
with heart failure. Adaptive servo-ventilation is a therapy that uses a noninvasive ventilator to …
with heart failure. Adaptive servo-ventilation is a therapy that uses a noninvasive ventilator to …
Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart.
BACKGROUND In chronic heart failure, the positive inotropic effects of beta-adrenergic
receptor agonists are greatly reduced, in part as a result of two alterations of the cardiac beta-…
receptor agonists are greatly reduced, in part as a result of two alterations of the cardiac beta-…
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis …
…, ME Weinblatt, D Van Der Heijde, E Erdmann… - The Lancet, 2006 - thelancet.com
Background Cyclo-oxygenase-2 (COX-2) selective inhibitors have been associated with an
increased risk of thrombotic cardiovascular events in placebo-controlled trials, but no clinical …
increased risk of thrombotic cardiovascular events in placebo-controlled trials, but no clinical …
Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]
JGF Cleland, JC Daubert, E Erdmann… - European heart …, 2006 - academic.oup.com
Aims The CArdiac REsynchronization-Heart Failure study randomized patients with left
ventricular ejection fraction ≤35%, markers of cardiac dyssynchrony, and persistent moderate or …
ventricular ejection fraction ≤35%, markers of cardiac dyssynchrony, and persistent moderate or …